Accessibility Menu
Im Cannabis logo

Im Cannabis

(NASDAQ) IMCC

Current Price$0.14
Market Cap$439.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-100%
5 Year-100%
1 Year-96%
1 Month-45%
Im Cannabis last closing stock price
MetricPriceDate
Last closeUSD 0.142026-07-16
Im Cannabis stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-11.61%USD 0.162026-07-09
1 month-45.23%USD 0.262026-06-16
3 month-62.43%USD 0.382026-04-17
Year to date-89.76%USD 1.392025-12-31
1 year-95.6%USD 3.242025-07-16
3 year-97.3%USD 5.282023-07-17
5 year-99.95%USD 308.402021-07-16
Since inception-99.88%USD 122.402020-05-29

Im Cannabis Financials at a Glance

Market Cap

$439.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$44.12M

Net Income (TTM)

-CA$11.09M

EPS (TTM)

-$1.82

P/E Ratio

-0.08

Dividend

$0.00

Beta (Volatility)

0.68 (Low)

Price

$0.14

Volume

111

Open

$0.14

Previous Close

$0.14

Daily Range

$0.14 - $0.14

52-Week Range

$0.12 - $3.61

Estimated Earnings Date

Aug 17, 2026

IMCC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Im Cannabis

IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods across international markets, including Israel, Germany, and Canada. The company offers a diverse range of cannabis products, including flowers and extracts, marketed under its IMC brand, as well as dried flower and pre-rolled products through its WAGNERS and Highland Grow labels.

Products and Services
  • Medicinal cannabis products for medical patients
  • Recreational cannabis offerings for adult consumers
  • Variety of cannabis formats, including flowers and extracts
Growth Outlook
  • Expansion into European markets enhances revenue potential
  • Increasing demand for medicinal cannabis supports growth
  • Strategic partnerships may drive product innovation and market reach
Financial Highlights
  • Recent quarterly revenue of 6.33 million CAD shows potential recovery
  • Trailing twelve months (TTM) revenue of 63.27 million CAD indicates growth
  • Operating income improved to -1.22 million CAD in the latest quarter
IM Cannabis Corp. is positioned in the rapidly growing cannabis industry, focusing on both medicinal and recreational markets. The company's diverse product offerings cater to a wide range of consumer needs, which may enhance its market presence. Recent financial data indicates a potential recovery, with quarterly revenue showing improvement and a focus on expanding into European markets. The strategic partnerships and increasing demand for cannabis products further support a positive growth outlook. Investors may find IM Cannabis Corp. an intriguing opportunity within the healthcare sector, particularly as the global cannabis market continues to evolve.
AI Generated • Jun 24, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

44

CEO

Oren Shuster

Website

imcannabis.com

Headquarters

Tel Aviv, 4690500, IL

IMCC Financials

Key Financial Metrics (TTM)

Gross Margin

27.28%

Operating Margin

-0.76%

Net Income Margin

-0.53%

Return on Equity

-3.03%

Return on Capital

-75.20%

Return on Assets

-0.33%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$439.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.09M

Volume

111

Avg. Volume

4.25M

Financials (TTM)

Gross Profit

CA$7.25M

Operating Income

-CA$8.54M

EBITDA

-CA$5.03M

Operating Cash Flow

-CA$1.50M

Capital Expenditure

-CA$15.41K

Free Cash Flow

-CA$1.51M

Cash & ST Invst.

CA$1.15M

Total Debt

CA$14.95M

Im Cannabis Performance Analysis

Im Cannabis annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 41,736,64753.7%
20232023-12-31CAD 36,159,496-13.4%
20242024-12-31CAD 39,439,7929.1%
20252025-12-31CAD 39,169,432-0.7%
Im Cannabis sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-301.6%
Q32025-09-309.1%
Q42025-12-31-18.8%
Q12026-03-31-43.7%
Im Cannabis annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -121.23726.6%
20232023-12-31CAD -3.29-97.3%
20242024-12-31CAD -3.29-0.1%
20252025-12-31CAD -1.91-41.9%
Im Cannabis sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-206.4%
Q32025-09-30-691.1%
Q42025-12-31-70.7%
Q12026-03-31-21773.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$6.33M

-49.4%

Gross Profit

CA$1.03M

-70.0%

Gross Margin

16.35%

N/A

Market Cap

$439.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$9.99K

N/A

Employees

44

N/A

Net Income

-CA$1.66M

-703.6%

EBITDA

-CA$859.51K

-238.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$1.15M

-17.1%

Total Debt

CA$14.95M

-5.3%

Accounts Receivable

CA$7.16M

-57.0%

Inventory

CA$2.00M

-63.2%

Long Term Debt

CA$811.43K

+57.9%

Short Term Debt

CA$14.15M

-7.3%

Return on Assets

-0.33%

N/A

Return on Invested Capital

-3.24%

N/A

Free Cash Flow

-CA$191.00K

-104.3%

Operating Cash Flow

-CA$186.00K

-104.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AKANAkanda Corp.
$9.57-4.30%
VEROVenus Concept Inc.
$0.31+2.64%
GRIGRI Bio, Inc.
$1.54-4.94%
JAGXJaguar Health, Inc.
$1.34-31.54%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$27.51-0.12%
NOKNokia
$10.38-0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$70.74-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.89+0.05%

Questions About IMCC

What is the current price of Im Cannabis?

Im Cannabis is trading at $0.14 per share.

What is the 52-week range for Im Cannabis?

Over the past 52 weeks, Im Cannabis has traded between $0.12 and $3.61.

How much debt does Im Cannabis have?

As of the most recent reporting period, Im Cannabis reported total debt of CA$10.72M.

How much cash does Im Cannabis have on hand?

Im Cannabis reported CA$825.48K in cash and cash equivalents in its most recent financial results.

What is Im Cannabis’s dividend yield?

Im Cannabis does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services